Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANIK | AMGN | GILD | VRTX | BIIB |
| Company | Anika Therapeutics | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 25.10 | 269.93 | 68.27 | 400.00 | 198.73 |
| High | 25.43 | 270.93 | 68.46 | 402.49 | 199.53 |
| Low | 24.97 | 264.35 | 67.70 | 396.69 | 196.40 |
| Last | 25.31 | 265.51 | 67.75 | 397.36 | 196.80 |
| Change | +0.31 | -1.77 | -0.32 | +0.81 | -1.38 |
| % Change | +1.24% | -0.66% | -0.47% | +0.20% | -0.70% |
| Volume | 37,400 | 1,740,100 | 7,717,800 | 1,373,700 | 1,159,200 |
| 20-Day Average Volume | 76,595 | 2,348,660 | 6,525,295 | 912,345 | 1,116,865 |
| Previous Close | 25.00 | 267.28 | 68.07 | 396.55 | 198.18 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 25.56 | 274.13 | 71.23 | 409.48 | 210.27 |
| 20-Day Raw Stochastic | 21.03% | 4.81% | 1.95% | 13.00% | 1.58% |
| 20-Day Relative Strength | 50.89% | 38.68% | 31.69% | 39.01% | 30.57% |
| Weighted Alpha | +3.01 | +5.78 | -22.75 | +17.20 | -35.90 |
| Today's Opinion | 80% Buy | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Previous Opinion | 64% Buy | 40% Sell | 100% Sell | 24% Buy | 100% Sell |
| Last Month's Opinion | 80% Buy | 8% Sell | 40% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.98% since 04/08/24 | -1.37% since 04/08/24 | -2.41% since 04/08/24 | -1.70% since 04/08/24 | -3.98% since 04/08/24 |
| Low | 24.90 on 04/12/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 393.76 on 04/12/24 | 196.40 on 04/15/24 |
| High | 26.44 on 04/09/24 | 273.00 on 04/11/24 | 69.95 on 04/09/24 | 406.45 on 04/09/24 | 209.06 on 04/09/24 |
| 1-Month | |||||
| %Chg | -0.51% since 03/15/24 | -1.25% since 03/15/24 | -8.06% since 03/15/24 | -2.53% since 03/15/24 | -10.26% since 03/15/24 |
| Low | 24.90 on 04/12/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 393.76 on 04/12/24 | 196.40 on 04/15/24 |
| High | 26.85 on 04/04/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +13.09% since 01/12/24 | -13.38% since 01/12/24 | -21.57% since 01/12/24 | -8.32% since 01/12/24 | -20.68% since 01/12/24 |
| Low | 21.00 on 03/14/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 393.76 on 04/12/24 | 196.40 on 04/15/24 |
| High | 27.31 on 03/06/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | +35.49% since 10/13/23 | -6.54% since 10/13/23 | -12.75% since 10/13/23 | +7.11% since 10/13/23 | -24.96% since 10/13/23 |
| Low | 18.08 on 10/25/23 | 249.70 on 10/31/23 | 67.62 on 04/12/24 | 341.90 on 11/16/23 | 196.40 on 04/15/24 |
| High | 27.31 on 03/06/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 269.43 on 10/17/23 |
| Key Statistics | |||||
| Market Capitalization, $K | 371,250 | 143,240,432 | 84,752,392 | 102,491,920 | 28,807,640 |
| Shares Outstanding, K | 14,850 | 535,919 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 166,660,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -82,670,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 42,970,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -63,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | 0.76 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -4.30 on 03/13/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 10.13 | 29.51 | 13.45 |